Bacillus subtilis is a Gram-positive bacterium recognized for its ability to secrete proteins efficiently, achieve high production yields, and its non-toxic nature, making it a valuable host for recombinant protein production . Its safety status (generally recognized as safe, GRAS) and capacity to incorporate exogenous DNA into its genome further establish it as an ideal platform for expressing bioactive substances . Advancements in genetic manipulation and proteomic analysis have significantly enhanced protein production in B. subtilis .
Bacillus subtilis is a widely utilized microbial cell factory, especially for proteins used in foods and food processing . Its value is enhanced by extensive scientific knowledge gained over decades, which has led to the development of various genetic engineering strategies, including different plasmids, engineered promoters, chemical inducers, and self-inducing expression systems . These tools improve the efficiency and reduce the costs of producing biotechnologically important proteins .
UPF0297 protein YrzL is a protein found in Bacillus subtilis (strain 168) .
Recent progress in genetic manipulation and proteomic analysis has greatly improved protein production in B. subtilis . Key advancements include genome-editing technologies and the application of the CRISPR-Cas9 system . Additionally, understanding the genes and operons crucial for secretory protein production allows for alterations that improve protein production .
The optimization of B. subtilis strains involves undirected chemical/physical mutagenesis, selection, and genetic manipulation . Enhancement and regulation of expression include autonomous plasmid and integrated expression, promoter regulation and engineering, and fine-tuning gene expression based on proteases and molecular chaperones .
Improving secretion levels primarily involves screening and optimizing secretion pathways and signal peptides . Surface display of proteins, whether on spores or vegetative cells, presents significant potential for various applications .
Fermentation optimization includes medium optimization, process condition optimization, and feeding strategy optimization .
B. subtilis strains can produce antimicrobial secondary metabolites. For example, Bacillus subtilis BS21 has seven gene clusters involved in the biosynthesis of antimicrobial compounds, including non-ribosomal peptides (bacillibactin, fengycin, surfactin, and zwittermicin A), a ribosomal peptide (subtilosin A), a dipeptide (bacilysin), and a polyketide (bacillaene) .
Bacillus subtilis strain FYZ1-3, isolated from tobacco waste, can withstand high temperatures and grow at 0.6% nicotine content . It exhibits a strong capacity for decomposing tobacco-derived starch and protein, with significant amylase and protease activity . Genomic analysis of FYZ1-3 predicts 10 secondary metabolites, with 8 functional synthetic gene clusters and 2 unknown clusters, suggesting the potential for new active substance synthesis .
| Gene Cluster | Similarity |
|---|---|
| Lignosulfan | 100% |
| Sactipeptides | 100% |
The FYZ1-3 strain contains 44 wool sulfur antimicrobial peptide gene clusters, related to its antibacterial properties . It also contains complete Fengycin synthase regulatory genes, indicating a strong inhibitory effect on filamentous fungi .
YrzL belongs to the uncharacterized protein family 0297 (UPF0297) in Bacillus subtilis. As an uncharacterized protein, it represents one of the numerous genes with unknown function, presenting both a challenge and opportunity for bacterial functional genomics. Understanding YrzL can provide insights into novel bacterial pathways and functions, potentially revealing new aspects of B. subtilis biology.
Methodological approach: For initial characterization, researchers should employ a combination of sequence-based bioinformatic analyses (conserved domains, homology modeling) alongside experimental approaches like the double-CRISPRi technique recently developed for B. subtilis genetic interaction mapping . This technique allows systematic quantification of genetic interactions at scale, which is particularly valuable for studying proteins of unknown function.
For optimal expression of YrzL, researchers should consider the specialized B. subtilis expression toolbox that comprises 60 expression vectors combining different promoters, secretion signals, and plasmid backbones . This system was specifically designed for potentially difficult-to-express proteins.
Methodological approach: Select from the available expression vectors based on your specific research needs:
For intracellular expression: Choose vectors with appropriate promoter strength without secretion signals
For secretory production: Select vectors containing strong secretion signals and translation-enhancing downstream box elements
Consider using the tailor-made clean deletion mutant strain described by researchers, which is protease and sporulation deficient with reduced autolysis
Methodological approach: Successful expression of recombinant YrzL can be validated through multiple complementary techniques:
Western blot analysis using tag-specific antibodies (if a tag was incorporated)
Mass spectrometry for protein identification
Activity assays (if function becomes known)
For secreted YrzL, analyze both cellular fraction and culture supernatant
Use fermentation strategies with controlled induction (e.g., acetoin-controlled overproduction) as described for other difficult-to-express B. subtilis proteins
Methodological approach: The double-CRISPRi method recently developed for B. subtilis provides a powerful approach for uncovering functional partners of targeted genes . To apply this to YrzL:
Design sgRNAs targeting yrzL and a library of other B. subtilis genes
Generate a pooled double knockdown library
Conduct fitness measurements to identify genetic interactions
Look for both negative (synthetic sickness) and positive (suppressive) interactions
Cluster genes with similar genetic interaction profiles to identify functional relationships
This approach has successfully identified new players in well-studied processes like cell division (e.g., yrrS, ytxG, and yerH were identified as potential new cell division genes) , and could similarly reveal the biological role of YrzL.
Methodological approach: For comprehensive phenotypic characterization of YrzL mutants:
Generate clean deletion mutants or CRISPRi knockdown strains of yrzL
Acquire multiple imaging modalities:
Phase-contrast imaging for cell morphology
Membrane staining (e.g., FM4-64) to visualize membrane structures
DAPI staining for nucleoid visualization
Implement computational segmentation to capture cell boundaries and quantify morphological parameters
Compare with known phenotypes of other gene knockouts
Conduct statistical analysis of morphological features (cell length, width, nucleoid distribution)
This approach revealed that novel genes like yrrS and ypbE exhibit normal morphology when deleted individually but show increased filamentation when combined with ezrA knockdown , demonstrating its value for phenotypic characterization.
Methodological approach: To investigate potential roles in cell division or envelope processes:
Generate genetic interactions with known cell division genes (e.g., ezrA, gpsB, sepF)
Analyze growth phenotypes of single and double mutants
Examine localization patterns using fluorescent protein fusions
Test for genetic interactions with cell envelope components, including lipoteichoic acid (LTA) and wall teichoic acid (WTA) synthesis genes
Look for correlations with other genes that exhibit strong negative genetic interactions with shape determination factors like MreB and Mbl
The actin homologs MreB and Mbl play distinct roles in B. subtilis cell shape determination and cell wall elongation, as revealed by recent genetic interaction studies .
Methodological approach:
Generate yrzL/mreB and yrzL/mbl double mutants or CRISPRi-mediated double knockdowns
Quantify growth phenotypes to detect genetic interactions
Use high-resolution microscopy to visualize MreB/Mbl localization patterns in yrzL mutants
Perform co-immunoprecipitation or bacterial two-hybrid assays to test for physical interactions
Analyze changes in peptidoglycan composition and synthesis in single and double mutants
If YrzL functions with MreB or Mbl, you might observe distinct genetic interaction profiles similar to the differential interactions observed between these proteins and processes like LTA/WTA synthesis and cell division .
Methodological approach for resolving conflicting localization data:
Compare multiple tagging approaches:
N-terminal vs. C-terminal fusions
Different fluorescent proteins with varying properties
Native promoter expression vs. inducible systems
Validate functionality of fusion proteins
Use complementary techniques:
Immunofluorescence with specific antibodies
Subcellular fractionation followed by Western blotting
Super-resolution microscopy techniques
Examine localization under different growth conditions and growth phases
Quantitative image analysis of co-localization with known cellular structures
Methodological approach:
Implement double-CRISPRi system to create conditional knockdowns of yrzL
Test growth under various stress conditions:
Envelope stress (antimicrobial compounds)
Oxidative stress
Nutrient limitation
Temperature stress
Identify conditional synthetic lethal interactions by screening yrzL knockdown in the presence of a library of other gene knockdowns
Analyze the genetic interaction landscape to identify condition-specific functions
Validate key interactions through single-cell imaging and growth assays
Methodological approach:
Screen multiple expression constructs from the B. subtilis toolbox of 60 expression vectors
Test different combinations of:
Promoter variants (test both available promoter options)
Four strong secretion signals if extracellular production is desired
Translation-enhancing downstream box elements
Three different plasmid backbones
Optimize fermentation conditions:
For potentially toxic proteins like oxidases, use the protease and sporulation deficient strain with reduced autolysis
Methodological approach:
Systematic optimization strategy:
Test expression at different temperatures (16°C, 25°C, 30°C, 37°C)
Vary induction conditions (concentration and timing)
Screen different strain backgrounds, including protease-deficient variants
Solubility enhancement approaches:
Co-expression with chaperones
Addition of solubility-enhancing tags
Expression as a fusion protein
Analysis of potential toxicity:
Monitor growth curves upon induction
Use tightly controlled inducible systems
Compare cell viability with and without induction
Apply specialized fermentation strategies developed for difficult-to-express proteins in B. subtilis
Methodological approach:
Implement comprehensive double-mutant analysis using double-CRISPRi technology as recently developed for B. subtilis
Design the experiment to:
Target yrzL and systematically pair with genome-wide gene knockdowns
Quantify genetic interactions at scale
Include essential genes in the analysis
Process data through specialized analysis pipelines to:
Discover genetic interactions
Identify functional partners of YrzL
Associate YrzL with specific pathways
Validate key interactions through experimental follow-ups:
Growth phenotype analysis
Microscopy
Biochemical assays
This approach has proven successful in discovering over 1000 known and novel genetic interactions in B. subtilis, revealing new genes involved in processes like cell division .
Methodological approach:
Analyze genetic interactions between yrzL and known cell envelope stress response genes:
Monitor expression of yrzL under envelope stress conditions:
Transcriptional reporter fusions
RT-qPCR analysis
Global transcriptome analysis
Examine phenotypes of yrzL mutants when exposed to:
Cell wall-targeting antibiotics
Membrane-disrupting compounds
Osmotic stress
The strong negative genetic interaction observed between bcrC and sigM in recent studies indicates the importance of such interactions for understanding envelope stress responses .